225 related articles for article (PubMed ID: 8072180)
1. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
[TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Sep; 46(9):794-800. PubMed ID: 8254899
[TBL] [Abstract][Full Text] [Related]
7. [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
Hayashi I; Inoue M; Hashimoto H
Jpn J Antibiot; 1994 Jun; 47(6):595-605. PubMed ID: 8072167
[TBL] [Abstract][Full Text] [Related]
8. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
Hayashi I; Inoue M; Hashimoto H
Drugs Exp Clin Res; 1994; 20(6):225-32. PubMed ID: 7758394
[TBL] [Abstract][Full Text] [Related]
9. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
[TBL] [Abstract][Full Text] [Related]
10. Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000).
Tsuchizaki N; Ishino K; Saito F; Ishikawa J; Nakajima M; Hotta K
J Antibiot (Tokyo); 2006 Apr; 59(4):229-33. PubMed ID: 16830890
[TBL] [Abstract][Full Text] [Related]
11. [A study on the resistance of methicillin resistant Staphylococcus aureus to antimicrobial agents].
Wang R; Nishioka K; Tanno Y
Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):95-8. PubMed ID: 8070299
[TBL] [Abstract][Full Text] [Related]
12. [An evaluation study on arbekacin for MRSA-infectious diseases including pneumonia, septicemia and others].
Odagiri S; Sumitomo M; Takahashi K; Matsumoto F; Sakurai I; Imai T; Yoshikawa K; Ito A; Sugiyama M; Suzuki M
Jpn J Antibiot; 1994 Jun; 47(6):751-62. PubMed ID: 8072184
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Tabata M; Shimizu M; Araake M; Ogawa H
Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. The Hanshin Study Group of Hematopoietic Disorders and Infections].
Hamazaki H; Horiuchi A; Hasegawa H; Masaoka T; Kitani T; Kanayama Y; Sugiyama H; Tatsumi N; Kageyama T; Uchino H
Jpn J Antibiot; 1994 Jun; 47(6):763-70. PubMed ID: 8072185
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital].
Yamazaki T; Endo K; Tominaga K; Fukuda M; Maesaki S; Hashikita G; Itabashi A
Kansenshogaku Zasshi; 2004 Apr; 78(4):305-11. PubMed ID: 15176234
[TBL] [Abstract][Full Text] [Related]
17. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Ishii T; Takayama Y; Takase Y; Orikasa Y
Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy of arbekacin on MRSA infections].
Ichiyama S; Shimokata K
Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
[TBL] [Abstract][Full Text] [Related]
20. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Kobayashi Y
Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
